Search - tctmd.com

Displaying 1 - 9 of 9

Sort: Relevancy | Date

Presentation ESC 2025

DANCAVAS 2: Screening and intervention to prevent cardiovascular disease and death

Presenter: Axel Diederichsen

August 30, 2025

Presentation ACC 2024

Comparison of an “Inclisiran First” Strategy With Usual Care in Patients With Atherosclerotic Cardiovascular Disease: Results From the VICTORION-INITIATE Randomized Trial

Presenter: Michael J. Koren

April 06, 2024

Presentation ACC 2023

A Randomized Trial Assessing The Impact Of Eliminating Copayment For High Value Preventive Medications For Low-income Seniors With Cardiovascular-related Chronic Diseases

Presenter: Braden Manns

March 06, 2023

Presentation TCT 2018

Advances in Digital Health May Help Prevent Cardiovascular Diseases: "E-Prevention"

Presenter: C. Michael Gibson, Mamas Mamas, Mohammad El Tahlawi

September 24, 2018

Presentation AHA 2017

Time at Blood Pressure Target and the Risk of Cardiovascular Diseases and Mortality

Presenter: Mar Pujades-Rodriguez

November 14, 2017

Presentation ESC 2017

Rivaroxaban With or Without Aspirin in Stable Cardiovascular Disease

Presenter: John Eikelboom

August 27, 2017

Presentation SCCT 2017

Non-obstructive Disease on Cardiovascular CT Should not Affect Primary Prevention

Presenter: Rita F. Redberg

July 10, 2017

Presentation TCT 2016

TCT 387: Sirolimus-Coated Balloons for the Prevention of Vascular Restenosis in Small Vessel Disease: Insights From the Nanoluté Registry

Presenter: Germano Di Sciascio, Bruno Scheller

November 01, 2016

Presentation

Availability and Affordability of Cardiovascular Disease Medicines and Their Effect on Use in High-, Middle-, and Low-Income Countries

Presenter: R. Khatib

October 26, 2015

Advertisement

DANCAVAS 2: Screening and intervention to prevent cardiovascular disease and death

Comparison of an “Inclisiran First” Strategy With Usual Care in Patients With Atherosclerotic Cardiovascular Disease: Results From the VICTORION-INITIATE Randomized Trial

A Randomized Trial Assessing The Impact Of Eliminating Copayment For High Value Preventive Medications For Low-income Seniors With Cardiovascular-related Chronic Diseases

Advances in Digital Health May Help Prevent Cardiovascular Diseases: "E-Prevention"

Time at Blood Pressure Target and the Risk of Cardiovascular Diseases and Mortality

Rivaroxaban With or Without Aspirin in Stable Cardiovascular Disease

Non-obstructive Disease on Cardiovascular CT Should not Affect Primary Prevention

TCT 387: Sirolimus-Coated Balloons for the Prevention of Vascular Restenosis in Small Vessel Disease: Insights From the Nanoluté Registry

Availability and Affordability of Cardiovascular Disease Medicines and Their Effect on Use in High-, Middle-, and Low-Income Countries

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content